Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Stockholders held by Anteris Technologies Global Corp. on December 3, 2025. The company is incorporated in Delaware and trades on the Nasdaq Global Market under the symbol AVR. A quorum was established with 20,980,141 shares present, representing approximately 54.6% of outstanding shares as of the October 30, 2025 record date.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting results. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the company's most recent 10-K or 10-Q filings for financial statements.
Material Changes and Voting Results
Shareholders approved all 13 proposals submitted at the Annual Meeting. Key outcomes include:
- Director Elections: John Seaberg and Gregory Moss were elected as Class I directors to serve until the 2028 annual meeting.
- Auditor Ratification: KPMG was ratified as the independent registered public accounting firm for the 2025 fiscal year.
- Executive Compensation (RSUs): Shareholders approved grants of Restricted Stock Units (RSUs) to various executives and directors in connection with the U.S. IPO and annual board appointments. Notable grants include:
- Wayne Paterson: 1,000,000 RSUs (IPO).
- John Seaberg: 83,333 RSUs (IPO) and $250,000 grant date value RSUs (Annual).
- Stephen Denaro: 41,666 RSUs (IPO) and $125,000 grant date value RSUs (Annual).
- Gregory Moss: 52,742 RSUs (Board appointment) and $61,644 grant date value RSUs (Annual).
- David Roberts: 52,742 RSUs (Board appointment) and $61,644 grant date value RSUs (Annual).
- Plan Amendments: Shareholders approved adjustments to the exercise price of certain stock options and amendments to the 2017 and 2020 Incentive Plans.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, or specific risk factors. The document focuses strictly on the procedural results of the shareholder vote. The approval of RSU grants and plan amendments indicates ongoing alignment of executive compensation with shareholder interests, subject to ASX Listing Rules.
Investor Verification Checklist
- Verify the final share count and voting percentages in the definitive Proxy Statement (Schedule 14A) filed on November 10, 2025.
- Review the specific terms and vesting schedules for the approved RSU grants in the Proxy Statement.
- Confirm the details of the exercise price adjustments and incentive plan amendments to assess potential dilution impacts.
- Check subsequent filings for the official appointment of the newly elected directors and the commencement of KPMG's audit engagement.